Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Thorax ; 74(4): 405-409, 2019 04.
Article in English | MEDLINE | ID: mdl-29440588

ABSTRACT

We report baseline results of a community-based, targeted, low-dose CT (LDCT) lung cancer screening pilot in deprived areas of Manchester. Ever smokers, aged 55-74 years, were invited to 'lung health checks' (LHCs) next to local shopping centres, with immediate access to LDCT for those at high risk (6-year risk ≥1.51%, PLCOM2012 calculator). 75% of attendees (n=1893/2541) were ranked in the lowest deprivation quintile; 56% were high risk and of 1384 individuals screened, 3% (95% CI 2.3% to 4.1%) had lung cancer (80% early stage) of whom 65% had surgical resection. Taking lung cancer screening into communities, with an LHC approach, is effective and engages populations in deprived areas.


Subject(s)
Community Health Services/organization & administration , Early Detection of Cancer/methods , Lung Neoplasms/diagnostic imaging , Poverty Areas , Aged , Community Health Services/methods , England/epidemiology , Female , Health Services Accessibility , Humans , Lung Neoplasms/epidemiology , Lung Neoplasms/etiology , Male , Mass Screening/methods , Middle Aged , Mobile Health Units , Pilot Projects , Prevalence , Smoking/adverse effects , Tomography, X-Ray Computed
2.
Health Expect ; 22(2): 162-172, 2019 04.
Article in English | MEDLINE | ID: mdl-30289583

ABSTRACT

BACKGROUND: In the United States, lung cancer screening aims to detect cancer early in nonsymptomatic current and former smokers. A lung screening pilot service in an area of high lung cancer incidence in the United Kingdom has been designed based on United States trial evidence. However, our understanding of acceptability and reasons for lung screening uptake or decline in a United Kingdom nontrial context are currently limited. OBJECTIVE: To explore with ever smokers the acceptability of targeted lung screening and uptake decision-making intentions. DESIGN: Qualitative study using semistructured focus groups and inductive thematic analysis to explore acceptability and uptake decision-making intentions with people of similar characteristics to lung screening eligible individuals. SETTING AND PARTICIPANTS: Thirty-three participants (22 ex-smokers; 11 smokers) men and women, smokers and ex-smokers, aged 50-80 were recruited purposively from community and health settings in Manchester, England. RESULTS: Lung screening was widely acceptable to participants. It was seen as offering reassurance about lung health or opportunity for early detection and treatment. Participant's desire to know about their lung health via screening was impacted by perceived benefits; emotions such as worry about a diagnosis and screening tests; practicalities such as accessibility; and smoking-related issues including perceptions of individual risk and smoking stigma. DISCUSSION: Decision making was multifaceted with indications that current smokers faced higher participation barriers than ex-smokers. Reducing participation barriers through careful service design and provision of decision support information will be important in lung screening programmes to support informed consent and equitable uptake.


Subject(s)
Decision Making , Intention , Lung Neoplasms/diagnosis , Mass Screening/psychology , Smokers/psychology , Aged , Aged, 80 and over , Early Detection of Cancer , Female , Focus Groups , Humans , Male , Middle Aged , Qualitative Research
3.
Thorax ; 74(7): 700-704, 2019 07.
Article in English | MEDLINE | ID: mdl-30420406

ABSTRACT

We report results from the second annual screening round (T1) of Manchester's 'Lung Health Check' pilot of community-based lung cancer screening in deprived areas (undertaken June to August 2017). Screening adherence was 90% (n=1194/1323): 92% of CT scans were classified negative, 6% indeterminate and 2.5% positive; there were no interval cancers. Lung cancer incidence was 1.6% (n=19), 79% stage I, treatments included surgery (42%, n=9), stereotactic ablative radiotherapy (26%, n=5) and radical radiotherapy (5%, n=1). False-positive rate was 34.5% (n=10/29), representing 0.8% of T1 participants (n=10/1194). Targeted community-based lung cancer screening promotes high screening adherence and detects high rates of early stage lung cancer.


Subject(s)
Early Detection of Cancer/methods , Lung Neoplasms/diagnosis , Mass Screening/methods , Public Health , Smoking/adverse effects , Tomography, X-Ray Computed/methods , Aged , Female , Humans , Incidence , Lung Neoplasms/epidemiology , Male , Middle Aged , Pilot Projects , Smoking/epidemiology , United Kingdom/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...